We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
GC Medical Science corp.

Smith & Nephew

Manufactures medical products and devices in the fields of Orthopaedic Reconstruction (joint replacement systems for ... read more Featured Products: More products

Download Mobile App




Smith & Nephew to Buy ArthroCare

By HospiMedica International staff writers
Posted on 11 Feb 2014
British medical technology company Smith & Nephew (London, United Kingdom) plans to buy medical device maker ArthroCare (Austin, TX, USA) to strengthen its sports medicine business.

The purchase price of approximately USD 1.7 billion, with an enterprise value of USD 1.5 billion, follows a strategic rationale of creating a comprehensive resection and repair portfolio with potential growth prospects. More...
The combination of ArthroCare’s radio frequency (RF) technology and Smith & Nephew’s strong mechanical blade portfolio will give customers a wider choice in resection technology. In joint repair, ArthroCare’s shoulder anchor innovation will complement Smith & Nephew’s strengths in knee repair.

The combined global footprint and channel presence will also add additional revenue opportunities from cross selling the combined portfolio and building upon shared capabilities in marketing and customer targeting. The adjacent Ear, Nose & Throat (ENT) business will also provide new growth opportunities. The acquisition will be subject to customary conditions, including a vote among ArthroCare shareholders and governmental clearances. ArthroCare will be integrated swiftly to minimize disruption to customers.

“ArthroCare and Smith & Nephew know each other well from our licensing and supply arrangements, and this is a natural transaction for both companies,” said David Fitzgerald, president and CEO of ArthroCare. “The Board believes that this transaction is in the best interest of our shareholders.”

“This is a compelling opportunity to add ArthroCare’s technology and highly complementary products to further strengthen our sports medicine business,” said Olivier Bohuon, CEO of Smith & Nephew. “Together, we will be able to generate significant additional revenue from the more comprehensive portfolio, combined sales force, and Smith & Nephew’s global footprint.”

Related Links:

Smith & Nephew 
ArthroCare



Platinum Member
STI Test
Vivalytic Sexually Transmitted Infection (STI) Array
Gold Member
POC Blood Gas Analyzer
Stat Profile Prime Plus
Imaging Table
Stille imagiQ2
PACS Workstation
PaxeraView PRO
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Surgical Techniques

view channel
Image: Professor Bumsoo Han and postdoctoral researcher Sae Rome Choi of Illinois co-authored a study on using DNA origami to enhance imaging of dense pancreatic tissue (Photo courtesy of Fred Zwicky/University of Illinois Urbana-Champaign)

DNA Origami Improves Imaging of Dense Pancreatic Tissue for Cancer Detection and Treatment

One of the challenges of fighting pancreatic cancer is finding ways to penetrate the organ’s dense tissue to define the margins between malignant and normal tissue. Now, a new study uses DNA origami structures... Read more

Patient Care

view channel
Image: The portable biosensor platform uses printed electrochemical sensors for the rapid, selective detection of Staphylococcus aureus (Photo courtesy of AIMPLAS)

Portable Biosensor Platform to Reduce Hospital-Acquired Infections

Approximately 4 million patients in the European Union acquire healthcare-associated infections (HAIs) or nosocomial infections each year, with around 37,000 deaths directly resulting from these infections,... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.